|
Originally published In Press as doi:10.1074/jbc.M206780200 on November 20, 2002
J. Biol. Chem., Vol. 278, Issue 9, 7500-7509, February 28, 2003
Transcription Factor Decoy Molecules Based on a Peptide
Nucleic Acid (PNA)-DNA Chimera Mimicking Sp1 Binding Sites*
Monica
Borgatti ,
Ilaria
Lampronti ,
Alessandra
Romanelli§,
Carlo
Pedone§,
Michele
Saviano§,
Nicoletta
Bianchi ,
Carlo
Mischiati , and
Roberto
Gambari ¶
From the Department of Biochemistry and Molecular
Biology, Ferrara University, Via L.Borsari n.46, 44100 Ferrara, Italy,
§ Institute of Biostructure and Bioimaging, CNR,
80134 Napoli, Italy, and ¶ Biotechnology Centre, Ferrara
University, Via Fossato di Mortara 8/A, 44100 Ferrara, Italy
Peptide nucleic acids (PNAs) are DNA-mimicking
molecules in which the sugar-phosphate backbone is replaced by a
pseudopeptide backbone composed of N-(2-aminoethyl)glycine
units. We determined whether double-stranded molecules based on PNAs
and PNA-DNA-PNA (PDP) chimeras could be capable of stable interactions
with nuclear proteins belonging to the Sp1 transcription factor family
and, therefore, could act as decoy reagents able to inhibit molecular interactions between Sp1 and DNA. Since the structure of PNA/PNA hybrids is very different from that of the DNA/DNA double helix, they
could theoretically alter the molecular structure of the double-stranded PNA-DNA-PNA chimeras, perturbing interactions with
specific transcription factors. We found that PNA-based hybrids do not
inhibit Sp1/DNA interactions. In contrast, hybrid molecules based on
PNA-DNA-PNA chimeras are very effective decoy molecules, encouraging
further experiments focused on the possible use of these molecules for
the development of potential agents for a decoy approach in gene
therapy. In this respect, the finding that PDP-based decoy molecules
are more resistant than DNA/DNA hybrids to enzymatic degradation
appears to be of great interest. Furthermore, their resistance can even
be improved after complexation with cationic liposomes to which PDP/PDP
chimeras are able to bind by virtue of their internal DNA structure.
*
This work was supported by CNR-P.F. Biotecnologie,
Ministero dell'Università e della Ricerca Scientifica e
Tecnologica-PRIN-2002, CNR Agenzia 2000, Finalized Research funds (year
2001) from the Italian Ministry of Health, and Ministero
dell'Istruzione, Università e Ricerca-Contributo Straordinario
Decreto 4-10-2001.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
39-532-291448; Fax: 39-532-202723; E-mail: gam@unife.it.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Lampronti, M. T.H. Khan, M. Borgatti, N. Bianchi, and R. Gambari
Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences
Evid. Based Complement. Altern. Med.,
September 1, 2008;
5(3):
303 - 312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bezzerri, M. Borgatti, E. Nicolis, I. Lampronti, M. C. Dechecchi, I. Mancini, P. Rizzotti, R. Gambari, and G. Cabrini
Transcription Factor Oligodeoxynucleotides to NF-{kappa}B Inhibit Transcription of IL-8 in Bronchial Cells
Am. J. Respir. Cell Mol. Biol.,
July 1, 2008;
39(1):
86 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Dechecchi, E. Nicolis, V. Bezzerri, A. Vella, M. Colombatti, B. M. Assael, Y. Mettey, M. Borgatti, I. Mancini, R. Gambari, et al.
MPB-07 Reduces the Inflammatory Response to Pseudomonas aeruginosa in Cystic Fibrosis Bronchial Cells
Am. J. Respir. Cell Mol. Biol.,
May 1, 2007;
36(5):
615 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Abdelrahim, C. H. Baker, J. L. Abbruzzese, and S. Safe
Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
J Natl Cancer Inst,
June 21, 2006;
98(12):
855 - 868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Feriotto, A. Finotti, P. Volpe, S. Treves, S. Ferrari, C. Angelelli, F. Zorzato, and R. Gambari
Myocyte Enhancer Factor 2 Activates Promoter Sequences of the Human A{beta}H-J-J Locus, Encoding Aspartyl-{beta}-Hydroxylase, Junctin, and Junctate
Mol. Cell. Biol.,
April 15, 2005;
25(8):
3261 - 3275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Crinelli, M. Bianchi, L. Gentilini, L. Palma, M. D. Sorensen, T. Bryld, R. B. Babu, K. Arar, J. Wengel, and M. Magnani
Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity
Nucleic Acids Res.,
March 29, 2004;
32(6):
1874 - 1885.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|